Free Trial

Gilead Sciences (GILD) SEC Filings & 10K Form

Gilead Sciences logo
$109.98 -2.07 (-1.85%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$110.03 +0.05 (+0.05%)
As of 06/13/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Gilead Sciences SEC Filings

DateFilerForm TypeView
06/11/2025
5:55 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
5:58 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
6:01 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
6:10 PM
Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
5:52 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
6:31 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:55 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
3:16 PM
Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2025
2:16 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
10:44 AM
Capital World Investors (Filed by)
Gilead Sciences (Subject)
Form SCHEDULE 13G/A
05/08/2025
7:16 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:17 PM
Gilead Sciences (Issuer)
Kramer Kelly A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:18 PM
Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
7:26 PM
Gilead Sciences (Issuer)
Horning Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:20 PM
BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:22 PM
Gilead Sciences (Issuer)
LOVE TED W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:25 PM
Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
5:27 PM
Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:26 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
12:24 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:27 AM
BlackRock, Inc. (Filed by)
Gilead Sciences (Subject)
Form SCHEDULE 13G/A
04/16/2025
2:22 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
10:00 AM
Gilead Sciences (Subject)
Mercy Investment Services, Inc. (Filed by)
Form PX14A6G
03/27/2025
3:30 PM
Gilead Sciences (Filer)
Form DEF 14A
03/27/2025
3:31 PM
Gilead Sciences (Filer)
Form DEFA14A
03/27/2025
3:32 PM
Gilead Sciences (Filer)
Form ARS
03/20/2025
4:42 PM
Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2025
3:32 PM
Gilead Sciences (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
03/18/2025
3:37 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:16 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
6:08 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:12 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:15 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:41 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:04 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
5:10 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:42 PM
Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
02/19/2025
3:43 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
8:13 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:22 PM
Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
Form SCHEDULE 13G/A
"I'm risking my reputation on this" (Ad)

Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.

Claim your FREE copy of Crypto Revolution now.
02/13/2025
3:14 PM
Gilead Sciences (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/06/2025
3:24 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:11 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:09 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:15 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
4:47 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
2:31 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:18 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
2:46 PM
GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
01/03/2025
5:33 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2025
5:38 PM
Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:17 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SCHEDULE 13D/A
12/23/2024
7:26 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:15 PM
Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
Form SCHEDULE 13G/A
12/19/2024
3:19 PM
Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:27 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:22 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:48 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:51 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:24 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:05 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:13 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
1:43 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
7:10 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
1:35 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
5:14 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:15 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:31 PM
Bluestone Jeffrey (Reporting)
Gilead Sciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
3:15 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:13 PM
Gilead Sciences (Subject)
Form FWP
11/13/2024
8:02 AM
Gilead Sciences (Filer)
Form 424B5
11/06/2024
3:19 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:07 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:09 PM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:09 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:58 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
6:07 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:08 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:43 PM
Gilead Sciences (Subject)
Mercier Johanna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:45 PM
Gilead Sciences (Subject)
Parsey Merdad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:30 PM
Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:33 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:38 PM
Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:41 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:20 PM
Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
2:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
1:23 PM
Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Banks aren’t ready for this altcoin—are you? (Ad)

While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.

Click here to access the full report now.
08/08/2024
4:17 PM
Gilead Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
4:28 PM
Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
8:01 AM
Gilead Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
7:06 PM
Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:31 PM
ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:35 PM
ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GILD) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners